120 related articles for article (PubMed ID: 35612570)
1. Dapagliflozin partially restores reproductive function in MC4R KO obese female mice.
Cui L; Tan C; Huang L; Wang W; Huang Z; Geng F; Wu M; Chen X; Cowley M; Roelfsema F; Chen C
J Endocrinol; 2022 Jun; 254(2):65-76. PubMed ID: 35612570
[TBL] [Abstract][Full Text] [Related]
2. Deficient melanocortin-4 receptor causes abnormal reproductive neuroendocrine profile in female mice.
Chen X; Huang L; Tan HY; Li H; Wan Y; Cowley M; Veldhuis JD; Chen C
Reproduction; 2017 Mar; 153(3):267-276. PubMed ID: 28003536
[TBL] [Abstract][Full Text] [Related]
3. Hyperphagia in male melanocortin 4 receptor deficient mice promotes growth independently of growth hormone.
Tan HY; Steyn FJ; Huang L; Cowley M; Veldhuis JD; Chen C
J Physiol; 2016 Dec; 594(24):7309-7326. PubMed ID: 27558671
[TBL] [Abstract][Full Text] [Related]
4. Dapagliflozin restores insulin and growth hormone secretion in obese mice.
Huang Z; Huang L; Wang C; Zhu S; Qi X; Chen Y; Zhang Y; Cowley MA; Veldhuis JD; Chen C
J Endocrinol; 2020 Apr; 245(1):1-12. PubMed ID: 31977312
[TBL] [Abstract][Full Text] [Related]
5. Dapagliflozin Ameliorates Ovulation Disorders via Attenuating Activated Microglia-Mediated Hypothalamic Inflammation in HFD-Fed Mice.
Chen X; Xiao Z; Liu Q; Luo D; Cai Y; Fan M
Neuroendocrinology; 2024; 114(4):331-347. PubMed ID: 38147832
[TBL] [Abstract][Full Text] [Related]
6. Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion.
Martinelli CE; Keogh JM; Greenfield JR; Henning E; van der Klaauw AA; Blackwood A; O'Rahilly S; Roelfsema F; Camacho-Hübner C; Pijl H; Farooqi IS
J Clin Endocrinol Metab; 2011 Jan; 96(1):E181-8. PubMed ID: 21047921
[TBL] [Abstract][Full Text] [Related]
7. Impaired coordination of nutrient intake and substrate oxidation in melanocortin-4 receptor knockout mice.
Albarado DC; McClaine J; Stephens JM; Mynatt RL; Ye J; Bannon AW; Richards WG; Butler AA
Endocrinology; 2004 Jan; 145(1):243-52. PubMed ID: 14551222
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin-induced food intake and growth hormone secretion are altered in melanocortin 3 and 4 receptor knockout mice.
Shaw AM; Irani BG; Moore MC; Haskell-Luevano C; Millard WJ
Peptides; 2005 Oct; 26(10):1720-7. PubMed ID: 16005545
[TBL] [Abstract][Full Text] [Related]
9. Voluntary exercise delays monogenetic obesity and overcomes reproductive dysfunction of the melanocortin-4 receptor knockout mouse.
Irani BG; Xiang Z; Moore MC; Mandel RJ; Haskell-Luevano C
Biochem Biophys Res Commun; 2005 Jan; 326(3):638-44. PubMed ID: 15596147
[TBL] [Abstract][Full Text] [Related]
10. Time-Restricted Feeding Restored Insulin-Growth Hormone Balance and Improved Substrate and Energy Metabolism in MC4RKO Obese Mice.
Wang W; Huang Z; Huang L; Gao L; Cui L; Cowley M; Guo L; Chen C
Neuroendocrinology; 2022; 112(2):174-185. PubMed ID: 33735897
[TBL] [Abstract][Full Text] [Related]
11. Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats.
Devenny JJ; Godonis HE; Harvey SJ; Rooney S; Cullen MJ; Pelleymounter MA
Obesity (Silver Spring); 2012 Aug; 20(8):1645-52. PubMed ID: 22402735
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice.
Kumar KG; Sutton GM; Dong JZ; Roubert P; Plas P; Halem HA; Culler MD; Yang H; Dixit VD; Butler AA
Peptides; 2009 Oct; 30(10):1892-900. PubMed ID: 19646498
[TBL] [Abstract][Full Text] [Related]
13. Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse.
Haskell-Luevano C; Schaub JW; Andreasen A; Haskell KR; Moore MC; Koerper LM; Rouzaud F; Baker HV; Millard WJ; Walter G; Litherland SA; Xiang Z
FASEB J; 2009 Feb; 23(2):642-55. PubMed ID: 18971258
[TBL] [Abstract][Full Text] [Related]
14. Unaltered Hypothalamic Metabolic Gene Expression in Kiss1r Knockout Mice Despite Obesity and Reduced Energy Expenditure.
De Bond JP; Tolson KP; Nasamran C; Kauffman AS; Smith JT
J Neuroendocrinol; 2016 Oct; 28(10):. PubMed ID: 27601011
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the melanocortin-4-receptor nonsense mutation W16X in vitro and in vivo.
Bolze F; Rink N; Brumm H; Kühn R; Mocek S; Schwarz AE; Kless C; Biebermann H; Wurst W; Rozman J; Klingenspor M
Pharmacogenomics J; 2013 Feb; 13(1):80-93. PubMed ID: 21969101
[TBL] [Abstract][Full Text] [Related]
16. CRTC1 deficiency, specifically in melanocortin-4 receptor-expressing cells, induces hyperphagia, obesity, and insulin resistance.
Matsumura S; Miyakita M; Miyamori H; Kyo S; Ishikawa F; Sasaki T; Jinno T; Tanaka J; Fujita K; Yokokawa T; Goto T; Momma K; Takenaka S; Inoue K
FASEB J; 2022 Dec; 36(12):e22645. PubMed ID: 36349991
[TBL] [Abstract][Full Text] [Related]
17. Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model.
Jaikumkao K; Pongchaidecha A; Chueakula N; Thongnak L; Wanchai K; Chatsudthipong V; Chattipakorn N; Lungkaphin A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2021-2033. PubMed ID: 29572114
[TBL] [Abstract][Full Text] [Related]
18. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.
Wang D; Luo Y; Wang X; Orlicky DJ; Myakala K; Yang P; Levi M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301371
[TBL] [Abstract][Full Text] [Related]
19. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.
Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Jaiwongkam T; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
Toxicol Appl Pharmacol; 2017 Oct; 333():43-50. PubMed ID: 28807765
[TBL] [Abstract][Full Text] [Related]
20. Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review.
Valette M; Bellisle F; Carette C; Poitou C; Dubern B; Paradis G; Hercberg S; Muzard L; Clément K; Czernichow S
Int J Obes (Lond); 2013 Aug; 37(8):1027-35. PubMed ID: 23147118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
